Back

Targeting the PSMB9–NGAL/MMP9 Axis: a novel neutrophil-driven mechanism and precision target for vascular remodeling in PAH

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pre-clinical Pulmonary Embolism (PE) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Xuyu He

Guangdong General Hospital Guangdong Cardiovascular Institute, Guangzhou (China)

5 More presentations in this session

Presentation thumbnail
Insulin resistance genetic susceptibility drives pulmonary arterial hypertension through monocyte metabolic reprogramming and immune dysregulation
Mr S. Hou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Interleukin-22–STAT3 Signaling Preserves Structural Integrity in the Pressure-Overloaded Right Ventricle
Doctor K. Shibao (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Prophylactic ranolazine and trimetazidine attenuate right ventricular dysfunction and improve exercise capacity in experimental pulmonary hypertension
Doctor A. Oz (Istanbul, TR) Miss S. Asal (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension
Doctor A. Garcia-Alvarez (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Myo-inositol trispyrophosphate improves oxygen delivery and right ventricular function in rat pressure overload model
Doctor M. Maczewski (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary hypertension: pre-clinical

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients
1 July 2021
thumbnail
Congress Presentation
Activation of prostaglandin E2 receptor 4 ameliorates pulmonary vascular remodeling and pulmonary hypertension via suppression of MEK/ERK activation
30 August 2025
thumbnail
Congress Presentation
Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
3 September 2019
thumbnail
Congress Presentation
Deficiency of myeloid prolyl hydroxylase domain proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signaling
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources